Racho, Krizzia Zahirah A.
HRN: 26-87-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2025
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
03/28/2025
04/04/2025
PO
0.8 Ml
Q 12
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes